StockWatch
·

Piramal Pharma Ltd

BSE: 543635

values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-123.36559.861.2K1.9KQ3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27

Margin Trend

percentage
OPM %NPM %
0.919.8618.8027.75Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
PeriodQ2 FY27Q1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25
INCOME
Revenue1.3K+19.6%1.1K-24.5%1.5K+24.5%1.2K+6.1%1.1K+16.2%969.88-42.6%1.7K+35.4%1.2K
Other Income137.93+20.3%114.63-37.6%183.69+91.0%96.15-52.4%201.97+11.6%180.92+357.9%39.51+60.0%24.70
Total Income1.5K+19.7%1.2K-25.9%1.7K+29.5%1.3K-2.8%1.3K+15.5%1.2K-33.5%1.7K+35.8%1.3K
EXPENSES
Expenditure1.3K+15.5%1.1K-14.5%1.3K+14.9%1.1K+2.6%1.1K+7.3%1.0K-26.1%1.4K+22.6%1.1K
Tax53.86+49.6%36.00-48.7%70.22+169.9%26.02-49.1%51.08+73.5%29.44-66.2%87.09+114.5%40.61
PROFIT
PBT224.60+50.3%149.48-55.0%331.85+114.2%154.93-37.4%247.41+73.5%142.58-60.9%364.36+128.6%159.41
Net Profit170.74+50.5%113.48-56.6%261.63+103.0%128.91-34.3%196.33+73.5%113.14-59.2%277.27+133.4%118.80
KEY METRICS
OPM %12.75%+2.35pp10.40%-5.57pp15.97%+4.24pp11.73%+0.46pp11.27%+6.70pp4.57%-20.08pp24.65%+20.64pp4.01%
NPM %11.51%+2.36pp9.15%-6.49pp15.64%+5.66pp9.98%-4.79pp14.77%+4.94pp9.83%-6.20pp16.03%+6.70pp9.33%
EPS1.29+51.8%0.85-56.9%1.97+103.1%0.97-34.5%1.48+74.1%0.85-59.3%2.09+132.2%0.90

Corporate Events

Board MeetingPPLPHARMA
2026
27Oct

Board Meeting

The meeting of the Board of Directors of the Company will be…

BSE Filing ↗
Board MeetingPPLPHARMA
2026
30Jul

Board Meeting

The 6th Annual General Meeting is scheduled to be held on Th…

BSE Filing ↗
Board MeetingPPLPHARMA
2024
23Oct

Board Meeting

Unaudited Financial Results (Standalone and Consolidated) of…

BSE Filing ↗
Board MeetingPPLPHARMA
2024
10May

Board Meeting

Consider and approve Audited Financial Results (Standalone a…

BSE Filing ↗
Board MeetingPPLPHARMA
2024
30Jan

Board Meeting

Consider and approve the Unaudited Financial Results for the…

BSE Filing ↗
Board MeetingPPLPHARMA
2023
27Oct

Board Meeting

Consideration and approval of Unaudited Financial Results (S…

BSE Filing ↗